NAD+ and Disease: What the Research Is Showing
Preview text: Parkinson's, heart failure, long COVID—and where NAD+ fits in.

Using this email in an article? Credit: AboutNAD email via They Sent It, with a link to this page. Full-size image
Use this example
Sent just before and after
| Nov 11, 2026 7:07 PM | NAD+ and Disease: What the Research Is Showing (this email) | |
| Nov 11, 2026 2:00 AM | What Is the NAD Metabolome? | |
| Nov 6, 2026 7:13 PM | What Is NR or Nicotinamide Riboside? | |
| Nov 4, 2026 7:06 PM | What Is NR or Nicotinamide Riboside? | |
| Oct 30, 2026 8:12 PM | What Are NAD+ Precursors? | |
| Oct 28, 2026 8:05 PM | What Are NAD+ Precursors? | |
| Oct 28, 2026 3:02 AM | Is Blood NAD+ Linked to Frailty? |
More from AboutNAD
All AboutNAD emailsNov 11, 2026 2:00 AM
What Is NR or Nicotinamide Riboside?
Nov 6, 2026 7:13 PM
What Is NR or Nicotinamide Riboside?
Nov 4, 2026 7:06 PM
Oct 30, 2026 8:12 PM
Oct 28, 2026 8:05 PM
Is Blood NAD+ Linked to Frailty?
Oct 28, 2026 3:02 AM
What NAD+ Is—and the 500+ Reactions It Fuels
Oct 23, 2026 8:11 PM
The First Benefit Data on Injectable NR
Oct 22, 2026 2:00 AM
Sent the same day by similar brands
Same ESP and the closest weekly volume, sent on Nov 11, 2026.










